It's an upgrade worth making, but it comes down to your privacy concerns.
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $3.18, representing a -3.34% change from its previous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results